Join us for an in-depth exploration of the complex landscape of plaque psoriasis and the innovative use of Anti-IL-17 sdAb for intralesional treatment. Our distinguished panel will discuss: - The significant unmet needs in plaque psoriasis treatment - Introduce our innovative approach with Anti-IL-17 NanoAbs: * Unique benefits of local administration * Key stages of drug development * Clinical implications for patients.

Register here.